CLX-1205

N/A

Report date: 2023/02/19 22:08:12

Base Information

Drug NameCLX-1205
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-2 inhibitorsTumor necrosis factor inhibitors
TargetsCyclooxygenase-2Tumor necrosis factor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalyxt Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalyxt Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A